Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Bovine Lactoferrin in Neonatal Sepsis and NEC
NCT04094597Phase 1Completed
- Sponsor
- Cairo University
- Start
- Jan 2018
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in neonatal sepsis, necrotizing enterocolitis (NEC) and anemia of prematurity (AOP) comparing Lactoferrin Arm with Placebo Arm (2 arms). Primary endpoints: Change in mortality rate of neonatal sepsis in preterm neonate at 1 year and Number of Preterm Neonates who will have long term Complication at 1 year. Started Jan 2018; status: completed.
02
Drugs
bovine lactoferrin
03
Conditions
neonatal sepsisnecrotizing enterocolitis (NEC)anemia of prematurity (AOP)
Beyond the preview
Go deeper on NCT04094597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04094597.